Skip to content
Catalyst

Eleutherococcus senticosusFinding

Eleutherococcus senticosus decreases tumour necrosis factor alpha concentration

lowersVery limited evidenceFindingreplicated ×1

01 · The sentence it was drawn from

“Compared with the Model group, both ASS 50 and 100 mg/kg groups significantly reduced the content of TNF-α and IL-1β in the Model group increased significantly (p < 0.01).”
Quoted verbatim from Acanthopanax senticosus Saponins Mitigate Left Ventricular Remodelling and Inhibit the Induction of MMP-2, MMP-9 in a Rat Model of Myocardial Infarction.
This finding among the 70 findings on its endpoint

Eleutherococcus senticosus

Tumour necrosis factor alpha concentration

lowers

Who
Male Wistar rats, 28 days after coronary artery (LAD) ligation to model myocardial infarction and left ventricular remodelling; serum TNF-α by ELISA kit; ASS 50 and 100 mg/kg groups against the untreated Model group
Dose studied
50 mg/kg or 100 mg/kg once daily by intragastric gavage

Very limited evidencePMID 41828600 · 2026

02 · The study

Study
animal · not in humans
Duration
4 weeks

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limitedthis finding
  • insufficient

03 · The paper

International journal of molecular sciences
What else it reported1 finding · 0 compounds · 1 endpoint

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M6ZW9806Q3QQMQTGQ9A1SSKP